Defining Patient-Centeredness in Healthcare

Published May 21, 2018

ISPOR Special Interest Group Presents Findings and Consensus Definition for “Patient Engagement” and “Patient-Centeredness”

Baltimore, MD, USA—May 21, 2018—ISPOR, the professional society for health economics and outcomes research, held a session this evening, “Defining Patient-Centeredness and Engagement in Health Economics and Outcomes Research: Proposed Definition and Stakeholder Response [F3],” at ISPOR 2018 in Baltimore, MD, USA. Patient-related initiatives in healthcare are expanding as more and more stakeholders seek to involve patients in drug development, research, and delivery of healthcare. The lack of a common definition for the terms “patient engagement” and “patient-centeredness” has made it difficult to quantify and measure the impact of related initiatives. When these terms are employed, they are often used interchangeably and/or not defined, which can lead to misunderstanding. This lack of a consistent, clear definition for these terms has been highlighted in outcomes research, pharmacoepidemiology, and related fields, as a barrier to implementing and measuring patient engagement in the field. The session was moderated by Rachel L. Harrington, BA, University of Illinois at Chicago, Chicago, IL, USA. Speakers included Eleanor M. Perfetto, PhD, MS, National Health Council, Washington, DC, USA and University of Maryland School of Pharmacy, Baltimore, MD, USA; Suzanne Schrandt, JD, Arthritis Foundation, Atlanta, GA, USA; and Sarah Donelson, MA, Genentech, San Francisco, CA, USA. In this session, speakers presented the proposed consensus definition of “patient engagement” suitable for use in the context of health economics and outcomes research. The proposed definition was derived from a multistep process that included a systematic review and qualitative analysis of existing definitions in addition to a multistakeholder review. The speakers shared the implications of and the response to a consensus definition for patient engagement from the perspective of key stakeholders, including patients, policy/research, and industry. The ISPOR Patient-Centered Special Interest Group, comprised of researchers and patient representatives, will submit a manuscript entitled, “Defining Patient Engagement in Research: Results of a Systematic Review and Analysis,” to the Society’s journal, Value in Health. Additional information on ISPOR 2018 can be found here. Released presentations from the conference can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORBaltimore.

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

ISPOR Announces 2026-2027 Board of Directors

May 26, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced its 2026-2027 board of directors who will assume office on July 1, 2026.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×